Robert W. Downs - Concepedia

Author

Robert W. Downs

Also Known As

R Downs, R W Downs, R. Downs, R. W. DOWNS, R. W. Downs, R. W. Downs,, R.W. Downs, ROBERT W. DOWNS, Robert Downs, Robert W Downs

Publications

8.7K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health Virginia Commonwealth University Medical Center National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Diabetes and Digestive and Kidney Diseases Virginia Commonwealth University

About

Robert W. Downs is an author at National Institutes of Health specializing in medicine, osteoporosis, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	2.4K
2	Health Sciences	7	7	501
3	Natural Sciences	6	6	278
4	Arts	1	1	79
5	Humanities	1	1	390

Robert W. Downs

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis Uri Liberman, Stuart Weiss, Johann Bröll, New England Journal of Medicine	1995	2.3K
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer, New England Journal of Medicine	2004	1.3K
The Hypocalciuric or Benign Variant of Familial Hypercalcemia: Clinical and Biochemical Features in Fifteen Kindreds Stephen J. Marx, Maurice F. Attie, Michael A. Levine, Medicine Author InformationHumanitiesOphthalmologyClass ConflictInherited Metabolic Disease	1981	390
Official Positions of the International Society for Clinical Densitometry E. Michael Lewiecki, Nelson B. Watts, Michael R. McClung, The Journal of Clinical Endocrinology & Metabolism Bone DiseaseBone ImagingOfficial PositionsMedicineInternational Health	2004	283
Resistance to multiple hormones in patients with pseudohypoparathyroidism Michael A. Levine, Robert W. Downs, Arnold M. Moses, The American Journal of Medicine UrologyParathyroid HormoneParathyroid DiseaseHormone TherapyEndocrinology	1983	256
Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism Michael A. Levine, Robert W. Downs, Maxine Singer, Biochemical and Biophysical Research Communications Molecular PhysiologySodium HomeostasisGeneticsPhysiologyHematology	1980	240
Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism Maurice F. Attie, J R Gill, John L. Stock, Journal of Clinical Investigation	1983	193
Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene Evaluation trial11Eli Lilly and Company (Indianapolis, IN) sponsored the Multiple Outcomes of Raloxifene Evaluation (MORE) trial. John А. Kanis, Olof Johnell, Dennis M. Black, Bone Bone DiseaseRheumatologySkeletal TraumaRaloxifene EvaluationClinical Trials	2003	189
Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women<sup>1</sup> Henry G. Bone, Robert W. Downs, Joseph Tucci, The Journal of Clinical Endocrinology & Metabolism	1997	188
The Long-term Effects of Gastric Bypass on Vitamin D Metabolism Jason M. Johnson, James W. Maher, Eric J. DeMaria, Annals of Surgery	2006	185

Page 1